NCT01860118View on ClinicalTrials.gov

LRRK2 and Other Novel Exosome Proteins in Parkinson's Disease

CompletedOBSERVATIONAL
Enrollment

601

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

June 21, 2016

Study Completion Date

June 21, 2016

Conditions
Parkinson's Disease
Trial Locations (1)

35294

University of Alabama at Birmingham Sparks Center, Birmingham

All Listed Sponsors
collaborator

National Institute of Neurological Disorders and Stroke (NINDS)

NIH

lead

University of Alabama at Birmingham

OTHER

NCT01860118 - LRRK2 and Other Novel Exosome Proteins in Parkinson's Disease | Biotech Hunter | Biotech Hunter